{
      "type": "article",
      "documents": [
          {
            "eprintid": 97684,
            "placement": 1,
            "content": "published",
            "format": "application/pdf",
            "main": "Jurayev_J.S._98-99.pdf",
            "language": "en",
            "files": [
                {
                  "filename": "Jurayev_J.S._98-99.pdf",
                  "mime_type": "application/pdf",
                  "datasetid": "document",
                  "uri": "https://arxiv.universalpublishings.com/id/file/148310",
                  "hash": "5c1fafc8edb88db62a0bd72b0832cc7c",
                  "fileid": 148310,
                  "hash_type": "MD5",
                  "mtime": "2026-06-19 06:18:55",
                  "filesize": 166338,
                  "objectid": 19308
                }
            ],
            "rev_number": 2,
            "docid": 19308,
            "pos": 1,
            "uri": "https://arxiv.universalpublishings.com/id/document/19308",
            "security": "public"
          }
      ],
      "full_text_status": "public",
      "number": 4,
      "rev_number": 3,
      "ispublished": "pub",
      "eprint_status": "archive",
      "publication": "INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION",
      "metadata_visibility": "show",
      "volume": 1,
      "status_changed": "2026-06-19 06:18:55",
      "date": "2024-05-12",
      "eprintid": 97684,
      "datestamp": "2026-06-19 06:18:55",
      "keywords": "extrahepatic manifestations, relapse, IFN + riboverine, retreatment of  relapse HCV RNA genotype 1b.",
      "title": "RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL  DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/97684",
      "creators": [
        {
          "name": {
            "lineage": null,
            "given": "Jurayev J.S.,",
            "family": "Jurayev J.S.,",
            "honourific": null
          }
        },
        {
          "name": {
            "lineage": null,
            "given": "Karshiev.M.A",
            "family": "Karshiev.M.A",
            "honourific": null
          }
        },
        {
          "name": {
            "family": "Uralov A.A",
            "honourific": null,
            "lineage": null,
            "given": "Uralov A.A"
          }
        }
      ],
      "lastmod": "2026-06-19 06:18:55",
      "pagerange": "98-99",
      "dir": "disk0/00/09/76/84",
      "official_url": "https://universalconference.us/index.php/icmse/article/view/1301",
      "abstract": "Viral hepatitis C is one of the leading liver diseases. According to WHO, 70 million people are infected with this disease. HCV kills 290,000 people every year. In 95% of patients, the disease becomes chronic, and the main complications are fibrosis and cirrhosis of the liver. In some cases, a relapse is observed, despite treatment with antiviral drugs."
    }